Skip to main content
NMR
NYSE Finance

Nomura Reports Strong Q3 Earnings, Completes $1.8B Acquisition, Announces Share Buyback & Cancellation

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
9
Price
$9.14
Mkt Cap
$27.435B
52W Low
$4.86
52W High
$9.47
Market data snapshot near publication time

summarizeSummary

This 6-K filing from Nomura Holdings presents a robust financial update, demonstrating solid growth in key metrics and strategic corporate actions. The reported increase in net revenue and net income, coupled with an improved Return on Shareholders' Equity, indicates healthy operational performance. The completion of the $1.8 billion acquisition of Macquarie's asset management entities significantly expands Nomura's global investment management capabilities and market presence. Furthermore, the approval of a substantial share buyback program and a separate share cancellation initiative underscores the company's commitment to enhancing capital efficiency and returning value to shareholders. These combined actions are likely to be viewed very positively by the market, reinforcing investor confidence, especially as the stock trades near its 52-week high. This filing provides concrete financial data following the previous day's 6-K which highlighted governance improvements and ROE.


check_boxKey Events

  • Strong Financial Performance

    Net revenue increased 10.5% to 1,590.5 billion yen, and net income attributable to shareholders rose 7.2% to 288.2 billion yen for the nine months ended December 31, 2025. Annualized Return on Shareholders' Equity improved to 10.8%.

  • Major Acquisition Completed

    Nomura finalized the acquisition of Macquarie Management Holdings and related entities for approximately $1.8 billion (281.4 billion yen) on December 1, 2025, enhancing its global investment management platform.

  • Significant Share Buyback Program

    The Board approved a program to repurchase up to 100 million common shares (approximately 3.2% of issued shares) for a maximum of 60 billion yen, aiming to improve capital efficiency and for stock-based compensation.

  • Share Cancellation Approved

    The company also approved the cancellation of 75 million common shares (approximately 2.4% of issued shares), effective March 2, 2026, further enhancing shareholder value.


auto_awesomeAnalysis

This 6-K filing from Nomura Holdings presents a robust financial update, demonstrating solid growth in key metrics and strategic corporate actions. The reported increase in net revenue and net income, coupled with an improved Return on Shareholders' Equity, indicates healthy operational performance. The completion of the $1.8 billion acquisition of Macquarie's asset management entities significantly expands Nomura's global investment management capabilities and market presence. Furthermore, the approval of a substantial share buyback program and a separate share cancellation initiative underscores the company's commitment to enhancing capital efficiency and returning value to shareholders. These combined actions are likely to be viewed very positively by the market, reinforcing investor confidence, especially as the stock trades near its 52-week high. This filing provides concrete financial data following the previous day's 6-K which highlighted governance improvements and ROE.

في وقت هذا الإيداع، كان NMR يتداول عند ‏٩٫١٤ US$ في NYSE ضمن قطاع Finance، مع قيمة سوقية تقارب ٢٧٫٤ مليار US$. تراوح نطاق التداول خلال 52 أسبوعًا بين ‏٤٫٨٦ US$ و‏٩٫٤٧ US$. تم تقييم هذا الإيداع على أنه ذو معنويات سوقية إيجابية وبدرجة أهمية ٩ من 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed NMR - Latest Insights

NMR
Apr 28, 2026, 6:01 AM EDT
Filing Type: 6-K
Importance Score:
7
NMR
Apr 24, 2026, 7:41 AM EDT
Filing Type: 6-K
Importance Score:
8
NMR
Apr 24, 2026, 6:09 AM EDT
Filing Type: 6-K
Importance Score:
8
NMR
Apr 15, 2026, 7:34 AM EDT
Filing Type: 6-K
Importance Score:
8
NMR
Apr 14, 2026, 6:01 AM EDT
Filing Type: 6-K
Importance Score:
8
NMR
Apr 01, 2026, 6:01 AM EDT
Filing Type: 6-K
Importance Score:
7
NMR
Mar 02, 2026, 6:01 AM EST
Filing Type: 6-K
Importance Score:
7
NMR
Feb 06, 2026, 6:01 AM EST
Filing Type: 6-K
Importance Score:
8
NMR
Jan 30, 2026, 6:03 AM EST
Filing Type: 6-K
Importance Score:
9
NMR
Jan 30, 2026, 6:02 AM EST
Filing Type: 6-K
Importance Score:
7